Results of Cerebrovascular Diseases Treatment with Cellex
We review the treatment options for acute stroke patients and for chronic cerebral ischemia that involve medications with neuroprotective and neurotrophic action. New indigenous Russian medicine Cellex is described, including the results of its preclinical and clinical efficacy studies. We provide detailed results of double blind multicenter randomized study of Cellex in 480 acute stroke patients. Future perspectives of acute stroke and chronic cerebral ischemia treatment with Cellex are reviewed.